[Neonatal sepsis: bases and possibilities for immunotherapy and immunoprophylaxis. 2: Immunotherapy]
- PMID: 2234977
[Neonatal sepsis: bases and possibilities for immunotherapy and immunoprophylaxis. 2: Immunotherapy]
Abstract
The physiological immunodeficiency of preterm and term newborns is the major cause of their increased susceptibility to infections. Although nonspecific and specific host defence mechanisms are morphologically intact, there are functional and quantitative defects. Supportive immunotherapy is required to equalize these immunological defects. This article reviews topical possibilities for immunotherapy of neonatal sepsis (exchange transfusion, transfusion of fresh blood or fresh plasma, granulocyte transfusion, use of immunoglobulins, fibronectin, interferon and colony-stimulating factor).
Similar articles
-
Neonatal sepsis: the potential for immunotherapy.Clin Perinatol. 1988 Dec;15(4):755-71. Clin Perinatol. 1988. PMID: 3061698 Review.
-
Immunotherapy of neonatal septicemia.Pediatr Clin North Am. 1986 Jun;33(3):481-501. doi: 10.1016/s0031-3955(16)36038-2. Pediatr Clin North Am. 1986. PMID: 3520460 Review.
-
[Neonatal sepsis: bases and possibilities for immunotherapy and immunoprophylaxis. 3: Immunoprophylaxis].Padiatr Grenzgeb. 1990;29(5):373-6. Padiatr Grenzgeb. 1990. PMID: 2234978 Review. German.
-
Neutrophil transfusions in the treatment of neonatal sepsis.Am J Pediatr Hematol Oncol. 1989 Summer;11(2):227-34. Am J Pediatr Hematol Oncol. 1989. PMID: 2665551 Review.
-
Adjuvant therapy of secondary peritonitis.Scand J Gastroenterol Suppl. 1984;100:43-6. Scand J Gastroenterol Suppl. 1984. PMID: 6435238 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical